Article
Therapeutic Restoration of Systemic Multiomic Responses by Transglutaminase 2 inhibitor in Celiac Disease: A Gluten Challenge Approach
2025-11-03
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background and Aims</h4> Celiac disease (CeD) is an autoimmune disease triggered by dietary gluten in genetically predisposed individuals. Deamidation of gluten peptides by the CeD autoantigen and enzyme transglutaminase 2 (TG2) is central to the pathogenesis of CeD. Inhibition of TG2 with the specific inhibitor ZED1227 effectively prevents gluten-induced histological damage in CeD patients...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 92c0941f-75c0-56ad-965f-fab487f4ec04
- DOI
- 10.1101/2025.10.31.25339231
